NCT00669461View on ClinicalTrials.gov

Lubiprostone as a Treatment for Constipation in Parkinson's Disease

NATerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

ConstipationParkinson's Disease

Interventions

DRUG

Lubiprostone

Lubiprostone 24 mcg BID orally for 4 weeks

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Takeda

INDUSTRY

lead

University of Arkansas

OTHER

NCT00669461 - Lubiprostone as a Treatment for Constipation in Parkinson's Disease | Biotech Hunter | Biotech Hunter